Yesterday the New York Daily News reported that A-Rod and Major League Baseball were discussing a plea deal that would land him a 150-game suspension in lieu of gambling over a potential lifetime ban in the event he took an appeal of any Biogenesis-related discipline to arbitration. The report described a shaken A-Rod following his meeting with Major League Baseball on Friday.
Later in the day, however, his team denied the report:
We’re into he-said, he-said land. Or he-said, he-didn’t-say. It’s pretty impossible to know what’s really going on here given all of the agendas at play. MLB is obviously getting tough and is trying to send messages, but they also want to be seen being tough and sending a message, so it may lend itself to leaks and reports that aren’t exactly on the mark. Meanwhile, A-Rod and other players want to defend themselves — and to be seen as defending themselves so that maybe players don’t think they’re wavering — but they could still be trying to mitigate the fallout if MLB’s case against them is strong.
The most significant thing about plea deal talk? The idea that there can be plea deals in the context of a drug testing/punishment regime that is supposed to be an exercise in zero-tolerance and mechanical justice. A program that isn’t supposed to be about negotiation and leverage because such things introduce uncertainty into a program that isn’t supposed to carry any, by design.
Maybe the unique circumstances of the Biogenesis case necessitate that. But I feel like baseball’s drug program is going to be permanently affected by what transpires before this is all said and done.
Aaron Judge may be the talk of the town right now, but let’s not forget some of Major League Baseball’s more established sluggers. Take the Nationals’ Bryce Harper, for instance, who jumped on a full count during the first inning of Saturday’s game and postmarked the ball to the center field concourse in Chase Field.
Harper’s mammoth hit was the first career home run allowed by Diamondbacks’ rookie Anthony Banda. Banda quickly recovered with an inning-ending strikeout to Ryan Zimmerman, but was booted from his big league debut after Harper, Zimmerman and Anthony Rendon combined for a three-run spread in the sixth.
The first-inning homer also served another purpose: it extended Harper’s hitting streak to 15 games, the longest current streak in MLB this season. He’ll need four more games to tie the 19-game streak Royals’ infielder/outfielder Whit Merrifield established back in June.
The Nationals currently lead the Diamondbacks 4-2 in the bottom of the seventh inning.
Rangers’ right-hander Chi Chi Gonzalez is slated for Tommy John surgery, according to a report by Evan Grant of the Dallas Morning News. Gonzalez was placed on the 60-day disabled list back in early April with a partial UCL tear and was working towards a throwing program before getting sidelined with more elbow pain. He’s expected to miss the entirety of the 2018 season while recovering from the surgery.
This is the second straight season that has been derailed for Gonzalez due to injury. The 25-year-old starter pitched just 10 1/3 innings in 2016 after recovering from a torn UCL, and was optioned to Triple-A Round Rock to finish out the year after compiling an 8.71 ERA, 7.8 BB/9 and 6.1 SO/9 in three starts with the club. He showed more promise in Triple-A with a 4.70 ERA, 2.9 BB/9 and 5.9 SO/9 through 24 starts and 138 innings.
It’s a tough blow for the Rangers, who have seen Gonzalez healthy in just one major league season to date. General manager Jon Daniels told reporters that a recent MRI showed signs of weakening in the ligament, which disrupted the team’s plans to have the right-hander stick to a six- to eight-week recovery timetable after getting a platelet-rich plasma injection (via Stefan Stevenson of the Fort Worth Star-Telegram). The surgery is expected to take place next week and will put Gonzalez’s earliest return date sometime in September 2018.